New Age Alpha Advisors LLC acquired a new stake in AdaptHealth Corp. (NASDAQ:AHCO - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 230,950 shares of the company's stock, valued at approximately $2,503,000. New Age Alpha Advisors LLC owned 0.17% of AdaptHealth as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors also recently bought and sold shares of the business. GAMMA Investing LLC raised its position in shares of AdaptHealth by 175.2% in the 1st quarter. GAMMA Investing LLC now owns 7,473 shares of the company's stock worth $81,000 after buying an additional 4,758 shares during the period. Y Intercept Hong Kong Ltd purchased a new position in AdaptHealth during the 1st quarter worth approximately $114,000. Legato Capital Management LLC bought a new stake in AdaptHealth in the first quarter worth $167,000. Empirical Financial Services LLC d.b.a. Empirical Wealth Management increased its stake in AdaptHealth by 25.3% in the first quarter. Empirical Financial Services LLC d.b.a. Empirical Wealth Management now owns 15,871 shares of the company's stock valued at $172,000 after acquiring an additional 3,208 shares during the period. Finally, Guggenheim Capital LLC grew its stake in shares of AdaptHealth by 10.1% during the fourth quarter. Guggenheim Capital LLC now owns 16,613 shares of the company's stock valued at $158,000 after purchasing an additional 1,525 shares during the last quarter. 82.67% of the stock is owned by institutional investors and hedge funds.
AdaptHealth Trading Up 0.1%
Shares of AdaptHealth stock traded up $0.01 on Monday, reaching $9.20. 156,653 shares of the company were exchanged, compared to its average volume of 1,452,542. The firm has a market capitalization of $1.24 billion, a price-to-earnings ratio of 17.06, a price-to-earnings-growth ratio of 0.89 and a beta of 1.58. The stock has a fifty day moving average price of $9.09 and a 200-day moving average price of $9.31. AdaptHealth Corp. has a fifty-two week low of $7.11 and a fifty-two week high of $11.70. The company has a current ratio of 1.06, a quick ratio of 0.82 and a debt-to-equity ratio of 1.14.
Wall Street Analyst Weigh In
Several brokerages have issued reports on AHCO. Wall Street Zen upgraded shares of AdaptHealth from a "hold" rating to a "buy" rating in a research report on Saturday. Truist Financial cut their target price on shares of AdaptHealth from $14.00 to $13.00 and set a "buy" rating for the company in a research report on Monday, May 12th. Finally, Royal Bank Of Canada decreased their price target on shares of AdaptHealth from $14.00 to $13.00 and set an "outperform" rating on the stock in a research note on Thursday, May 8th. Six investment analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $13.40.
View Our Latest Report on AHCO
AdaptHealth Company Profile
(
Free Report)
AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.
Further Reading
Before you consider AdaptHealth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AdaptHealth wasn't on the list.
While AdaptHealth currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
